1-1 of 1
Andrew Raubtischek
Close
Sort by
Journal Articles

Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20 + B-cell lymphoma: long-term follow-up of a phase 1/2 study

Clinical Trials & Observations Brief Report
Leo I. Gordon, Arturo Molina, Thomas Witzig, Christos Emmanouilides, Andrew Raubtischek, Mohamed Darif, Russell J. Schilder, Greg Wiseman, Christine A. White
Journal: Blood
Blood (2004) 103 (12): 4429–4431.
https://doi.org/10.1182/blood-2003-11-3883
Published: 2004